Skip to main content

S32 — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

109
Companies
$11.2B
Total invested
$103.2M
Avg. check
39
Industries
Artificial Intelligence (AI) 16Biotechnology 10Therapeutics 8Health Care 7Information Technology 6Machine Learning 6+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 109
Cohere
October 2026

Cohere is an AI company that develops enterprise AI models, language-processing tools, and AI-powered solutions for businesses.

Artificial Intelligence (AI) · Toronto$5.0B Series E
Alector
October 2026

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Biotechnology · South San Francisco$50.0M Post-IPO Equity
Vir Biotechnology
October 2026

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Biotechnology · San Francisco$25.0M Post-IPO Equity
Celularity
September 2026

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Biotechnology · Florham Park$10.0M Post-IPO Debt
BigHat Biosciences
September 2026

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

Artificial Intelligence (AI) · San Mateo$75.0M Series C
Basecamp Research
September 2026

Basecamp Research is a biotechnology company that uses artificial intelligence and biological data to develop therapeutics.

Artificial Intelligence (AI) · London$140.0M Series C
Ema
September 2026

Ema is an artificial intelligence software company that develops AI agents for automating enterprise workflows.

Artificial Intelligence (AI) · Mountain View$77.0M Series B
Snorkel AI
September 2026

Snorkel AI develops specialized training data, evaluation systems, benchmarks, and environments for AI models and agents.

AI Infrastructure · San Francisco$350.0M Series E
UpDoc
September 2026

UpDoc is a technology-enabled services company that offers the first-ever proprietary conversational AI platform for autonomous.

Artificial Intelligence (AI) · Palo Alto$9.2M Grant
SciFin
September 2026

SciFin is an AI-powered revenue intelligence platform that unifies fragmented sales data & CRM information into a single context layer.

Artificial Intelligence (AI) · San Jose$44.0M Seed
Empirik
September 2026

Empirik is an agentic AI company that uses AI to predict and map the impact of infrastructure changes through an AI agent.

Agentic AI · Menlo Park$21.0M Seed
Linear
August 2026

Linear is a purpose-built tool for tracking issues, managing sprints, and organizing project roadmaps in software development teams.

Artificial Intelligence (AI) · San Francisco$99.0M Secondary Market
Faro AI
August 2026

Faro Health develops software to assists clinical development processes, including workflow automation and clinical trial design.

Artificial Intelligence (AI) · La Jolla$37.3M Series B
Network Bio
August 2026

Network Bio develops AI platforms designed to learn from human biology and support medical research and healthcare applications.

Artificial Intelligence (AI) · New York$50.0M Venture - Series Unknown
Relay Therapeutics
May 2026

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Biotechnology · Cambridge$275.0M Post-IPO Equity
Autoscience
March 2026

Autoscience uses science and tech to improve vehicle automation, safety, and performance.

San Mateo$14.0M Seed
RunSybil
March 2026

RunSybil is an AI-powered offensive security platform designed to continuously test applications and infrastructure for vulnerabilities.

Artificial Intelligence (AI) · San Francisco$40.0M Seed
Outtake
January 2026

Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.

Artificial Intelligence (AI) · Brooklyn$40.0M Series B
humans&
January 2026

humans& operates as a frontier artificial intelligence research and product lab focused on human-centered AI systems and interaction models.

AI Infrastructure · Redwood City$480.0M Seed
Aspen Neuroscience
November 2025

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Biotechnology · San Diego$115.0M Series C
Manifold Bio
October 2025

Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.

Biotechnology · Boston$1.0M Non-equity Assistance
Phaidra
October 2025

Phaidra provides AI and ML solutions to accelerate performance in large-scale industries.

Artificial Intelligence (AI) · Seattle$50.0M Series B
Character Biosciences
September 2025

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Artificial Intelligence (AI) · Jersey City$17.0M Series B
Owl AI
June 2025

Owl AI is a sports technology company that uses artificial intelligence to improve performance analytics and decision-making in sports.

Analytics · San Francisco$11.0M Seed

Where S32 invests

Artificial Intelligence (AI)16
Biotechnology10
Therapeutics8
Health Care7
Information Technology6
Machine Learning6

About S32's portfolio

How many companies has S32 invested in?▸

S32 has invested in 109 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does S32 invest in?▸

S32's top investment sectors include Artificial Intelligence (AI), Biotechnology, Therapeutics, Health Care, Information Technology. The firm invests across 39 different industry categories.

What is S32's largest investment?▸

Among tracked funding rounds, Cohere received $5.0B in a Series E round. S32's total known invested capital is $11.2B.

What is the average investment size for S32?▸

S32's average investment size is $103.2M across its portfolio of 109 companies.

What are S32's most recent investments?▸

Recent S32 portfolio additions include Cohere, Alector, Vir Biotechnology, Celularity, BigHat Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 109 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →